A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment...

Area of Science:

• Virology
• Clinical Trials
• Public Health

Background:

• Analytic treatment interruptions (ATIs) are standard in HIV cure research to evaluate antiretroviral therapy (ART)-free remission.
• ATIs pose significant risks, including potential HIV transmission, with limited established guidelines for mitigation.
• Recent reports highlight two HIV transmissions linked to ATIs, underscoring the urgent need for safety protocols.

Discussion:

• This work presents a practical framework for minimizing transmission risks during ATIs in clinical trials.
• It details specific strategies implemented in an upcoming trial designed to enhance participant and partner safety.
• The proposed methods aim to be adaptable for use by other research centers conducting similar studies.

Key Insights:

• ATIs, while essential for HIV cure research, necessitate robust safety measures due to inherent transmission risks.
• Proactive risk mitigation strategies are crucial for protecting individuals involved in ATI studies and their sexual contacts.
• Standardized safety protocols can enhance the ethical conduct and feasibility of HIV cure research involving ATIs.

Outlook:

• Further research and validation of risk mitigation strategies are needed to ensure participant safety in HIV cure trials.
• Implementation of these practical approaches may facilitate the advancement of HIV remission research globally.
• Continued vigilance and adherence to safety guidelines are paramount as research into sustained ART-free remission progresses.